REPOSITIONING & RARE DISEASES: A FAST DRUG DEVELOPMENT PROCESS.

posted on January 10, 2016

SOM Biotech is a repositioning clinical-stage biopharmaceutical company focused on Rare Diseases. Why repositioning and orphan? See this article to get the answer.

Chinese Version

English Version